Synaptogenix Inc (SNPX)

[MaxTok]

What we have with NTRP is the opposite of Spin and pump, which is equally unfair to investors. The data here seems strong with a clear path to market. There is a compelling case to be made, but the company is failing to to tell its story in a clear and coherent way. If it did, this stock would be trading at 5x or even 10x current value. I think if it would be great if a group of investors who have taken the time to look into the science of NTRP, would be granted a Q&A with Dr. Alkon and have a chance get mere insight into both the data and company strategy. A more coherent and clear narrative could be a game changer. Would anyone be interested to join in making a request for such a Q&A session?